Aktuellt
SENASTE
Redeye maintains a positive outlook on Nanologica following its Q2 report. Production has improved and it seems that the company is poised for growth in the near term. While we mostly maintain our fair value range, we have made some adjustments to our estimates.
LÄS MER
